The NMS impaired sleep quality (PSQI), cognitive deficits (MoCA), depression (PHQ-9), bladder dysfunction, restless legs syndrome (RLS) and pallhypesthesia were all highly significant more frequent in SCA3 patients compared to controls (Table 1 ).
← all excerpts
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors.
1
—
—